Myriad Genetics
MYGN
$18.18
Share price
1.11%
Change (1 day)
-13.35%
Change (1 year)
Myriad Genetics (MYGN) - Total assets
Total assets on the balance sheet as of December 2023 : $1.14 B
According to Myriad Genetics's latest financial reports the company's total assets are $1.14 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Myriad Genetics - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $1.14 B | -4.35% |
| 2022-12-31 | $1.19 B | -9.24% |
| 2021-12-31 | $1.32 B | |
| 2020-06-30 | $1.40 B | -10.12% |
| 2019-06-30 | $1.56 B | 32.96% |
| 2018-06-30 | $1.17 B | -2.78% |
| 2017-06-30 | $1.20 B | 37.3% |
| 2016-06-30 | $0.88 B | 14.92% |
| 2015-06-30 | $0.76 B | -6.99% |
| 2014-06-30 | $0.82 B | 2.49% |
| 2013-06-30 | $0.80 B | 16.39% |
| 2012-06-30 | $0.69 B | 13.07% |
| 2011-06-30 | $0.61 B | 2.86% |
| 2010-06-30 | $0.59 B | 27.33% |
| 2009-06-30 | $0.46 B | -6.6% |
| 2008-06-30 | $0.49 B | 32.97% |
| 2007-06-30 | $0.37 B | 35.77% |
| 2006-06-30 | $0.27 B | 74.01% |
| 2005-06-30 | $0.15 B | -15.61% |
| 2004-06-30 | $0.18 B | 3.03% |
| 2003-06-30 | $0.18 B | 16.16% |
| 2002-06-30 | $0.15 B | -8.57% |
| 2001-06-30 | $0.17 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $73.21 B | 6,285.87% | 🇺🇸 USA |
 Exact Sciences EXAS | $6.47 B | 464.44% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $6.84 B | 496.74% | 🇺🇸 USA |
 Biocept
BIOC | $22.1 M | -98.07% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $12.29 B | 972.75% | 🇺🇸 USA |